Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Allakos Inc ALLK

Healthcare Biotechnology
Allakos Inc. is a clinical-stage biotechnology company, which is engaged in the development of therapeutics that target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases. The Company’s most advanced product candidate, AK006, is in a Phase I clinical trial. AK006 targets Siglec-6, an inhibitory receptor expressed selectively... see more

Recent & Breaking News (NDAQ:ALLK)

ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Announces that a Securities Class Action Lawsuit has been Filed Against Allakos Inc.

Business Wire March 25, 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA March 25, 2020

WWE & ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Notifies Investors of Class Actions and Encourages Investors to Contact the Firm

ACCESSWIRE IA March 25, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK

GlobeNewswire March 24, 2020

Allakos Announces the Initiation of Antolimab (AK002) Clinical Studies

GlobeNewswire March 24, 2020

Allakos Announces Positive Phase 1 Results with Antolimab (AK002) in Mast Cell Gastrointestinal Disease

GlobeNewswire March 24, 2020

Allakos Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm

Newsfile March 24, 2020

ALLK ALERT: ROSEN, A LEADING FIRM, Reminds Allakos Inc. Investors of Important May 11th Deadline in Securities Class Action First Filed By Firm- ALLK

ACCESSWIRE IA March 23, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA March 21, 2020

ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Allakos Inc. Investors of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire March 20, 2020

ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Allakos Inc. Investors of Class Action and Encourages Investors with Losses in Exceeding $100,000 to Contact the Firm

ACCESSWIRE IA March 20, 2020

Allakos Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm

Newsfile March 20, 2020

ALLK SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Alerts Allakos Inc. Investors of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire March 19, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Allakos (ALLK) Investors with Losses to Contact Its Attorneys: Application Deadline Approaching

GlobeNewswire March 18, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Funko, Allakos, and Cronos Group and Encourages Investors to Contact the Firm

GlobeNewswire March 18, 2020

SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA March 18, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK

GlobeNewswire March 17, 2020

ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Allakos Inc. Investors of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

PR Newswire March 17, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA March 17, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Allakos (ALLK) Investors Who Have Suffered Losses to Contact Its Attorneys: Securities Fraud Class Action Deadlines Established

ACCESSWIRE IA March 16, 2020